Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Chromadex Corp CS (CDXC)

Chromadex Corp CS (CDXC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Chromadex Corp CS 10900 Wilshire Blvd. Suite 600 Los Angeles CA 90024 USA

P: 310-388-6706

Description:

ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. ChromaDex's core business strategy is to use the intellectual property harnessed by its expertise in the area of natural products and in the creation of reference materials to the industry as the basis for providing new and alternative, `green`, mass marketable products to its customers. The Company's main priority is to create industry-accepted information, and to provide products and services to every layer of the functional food, pharmaceutical, personal care and dietary supplement markets. The company markets and sells its products in the United States and Canada. It offers its products through distributors in Europe, South America, Korea, India, Japan, Australia, New Zealand, China, Indonesia, Malaysia, Singapore, Thailand, and Mexico.

Key Statistics

Overview:

Market Capitalization, $K 121,636
Shares Outstanding, K 68,335
Annual Sales, $ 67,450 K
Annual Net Income, $ -27,130 K
Last Quarter Sales, $ 17,260 K
Last Quarter Net Income, $ -7,740 K
60-Month Beta 1.78
% of Insider Shareholders 11.80%
% of Institutional Shareholders 29.64%
Float, K 60,271
% Float 88.20%
Short Volume Ratio 0.20

Growth:

1-Year Return -81.08%
3-Year Return -59.08%
5-Year Return -50.83%
5-Year Revenue Growth 151.59%
5-Year Earnings Growth -400.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.11 on 05/12/22
Next Earnings Date 08/02/22
Earnings Per Share ttm -0.40
EPS Growth vs. Prev Qtr -37.50%
EPS Growth vs. Prev Year 8.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-3 on 04/13/16

CDXC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -81.33%
Return-on-Assets % -46.38%
Profit Margin % -40.22
Net Margin % -59.24
Debt/Equity 0.00
Price/Sales 1.69
Price/Cash Flow N/A
Price/Book 4.41
Book Value/Share 0.38
Interest Coverage -451.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar